Katrina Ysabel Naraval MD , Mikhail Lew Perez Ver MD
{"title":"第七页。轻度腰椎滑脱患者使用椎板间装置(Coflex®)的临床和放射学结果:一项单中心研究","authors":"Katrina Ysabel Naraval MD , Mikhail Lew Perez Ver MD","doi":"10.1016/j.xnsj.2025.100631","DOIUrl":null,"url":null,"abstract":"<div><h3>BACKGROUND CONTEXT</h3><div>Lumbar spinal fusion relieves pain in degenerative spondylolisthesis (DLS) but carries postoperative risks, including pseudoarthrosis and adjacent segment degeneration and disease, which may eventually lead to reoperation. Dynamic stabilizers, like Coflex® interlaminar device, preserve motion while ensuring stability, providing symptom relief with fewer complications and a reduced risk profile. Though research varies, recent studies highlight their benefits in low-grade DLS.</div></div><div><h3>PURPOSE</h3><div>This study evaluated the radiologic and clinical effectiveness of Coflex® after decompression for low-grade DLS, with follow-ups at 1 to up to 6 years to assess outcomes and complications.</div></div><div><h3>STUDY DESIGN/SETTING</h3><div>This is an analytical retrospective cohort study from a single tertiary center including patients who had low-grade spondylolisthesis (Meyerding Gr I) and was treated with lumbar decompression with consequent interlaminar device (Coflex®) application performed by two fellowship-trained spine surgeons between January 1, 2017 and June 31, 2023. Ethical clearance was obtained (SL-23278).</div></div><div><h3>PATIENT SAMPLE</h3><div>Forty-seven patients who had low-grade spondylolisthesis (Meyerding Gr I) and treated with lumbar decompression with consequent interlaminar device (Coflex®) application were included.</div></div><div><h3>OUTCOME MEASURES</h3><div>Radiographic parameters – lumbar lordosis (LL), lower lumbar lordosis (LLL), intervertebral disc height (IDH), intervertebral foramen height (IFH), and vertebral translation (VT) – were obtained. Clinical outcomes were evaluated by visual analogue scale (VAS) and Oswestry disability Index (ODI).</div></div><div><h3>METHODS</h3><div>Primary outcomes were categorized as radiographic and clinical. Radiographic parameters and functional outcomes included were assessed preoperatively, postoperatively, at 1-year follow-up, and at =1-year follow-up. Descriptive statistics (mean, range, SD, frequency, percentage) were calculated. A paired Student*s t-test assessed differences in radiographic parameters and clinical outcomes. Comparisons were made across preoperative, immediate postoperative, 12-month follow-up, and latest follow-up (=1 year). Linear mixed model analysis with compound symmetry evaluated significant changes over time. Statistical significance was set at p< 0.05.</div></div><div><h3>RESULTS</h3><div>A total of 47 patients (mean age 57 years, range 30-92) with 50 implanted levels were included in the study. Following surgical decompression and interlaminar device placement, LL showed a slight but non-significant decrease [42.89° ± 10.08 to 40.33° ± 8.30 (p = 0.059)] and remained stable, while LLL remained unchanged. VT improved significantly from 3.82 mm ± 3.66 mm to 1.53 mm ± 1.84 mm (p < 0.001) and remained stable until the final follow-up (p = 0.922). IDH increased significantly from 10.23 mm ± 2.33 to 12.48 mm ± 3.11 (p < 0.001), and IFH from 20.55 mm ± 3.40 to 24.05 mm ± 3.78 (p < 0.001), both showing significant decreases at 12 months but stabilizing thereafter. Clinical outcomes, including VAS (p = 0.006) and ODI (p = 0.002), showed significant improvement compared to baseline, with continued improvement until the latest follow-up. One patient experienced infection, with no reports of adjacent segment disease or subsidence.</div></div><div><h3>CONCLUSIONS</h3><div>This study demonstrates that patients with low-grade DLS treated with posterior decompressive laminotomy and interlaminar device (Coflex®) achieve and sustain significant improvements in key radiologic parameters, including LL, LLL, and VT, and spinal motion for up to six years post-surgery with minimal risks or complications. Immediate postoperative improvements in IDH and IFH were observed, with only minor changes noted at long-term follow-up. Additionally, the findings show improvement in back pain and in functional outcomes, meeting the minimal clinically important differences for VAS and ODI scores compared to baseline.</div></div><div><h3>FDA Device/Drug Status</h3><div>Coflex® Interlaminar device (FDA PMA P110008) (Approved for this indication).</div></div>","PeriodicalId":34622,"journal":{"name":"North American Spine Society Journal","volume":"22 ","pages":"Article 100631"},"PeriodicalIF":2.5000,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"P7. Clinical and radiologic outcomes of the use of interlaminar device (Coflex®) among patients with low-grade lumbar spondylolisthesis: a single center study\",\"authors\":\"Katrina Ysabel Naraval MD , Mikhail Lew Perez Ver MD\",\"doi\":\"10.1016/j.xnsj.2025.100631\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>BACKGROUND CONTEXT</h3><div>Lumbar spinal fusion relieves pain in degenerative spondylolisthesis (DLS) but carries postoperative risks, including pseudoarthrosis and adjacent segment degeneration and disease, which may eventually lead to reoperation. Dynamic stabilizers, like Coflex® interlaminar device, preserve motion while ensuring stability, providing symptom relief with fewer complications and a reduced risk profile. Though research varies, recent studies highlight their benefits in low-grade DLS.</div></div><div><h3>PURPOSE</h3><div>This study evaluated the radiologic and clinical effectiveness of Coflex® after decompression for low-grade DLS, with follow-ups at 1 to up to 6 years to assess outcomes and complications.</div></div><div><h3>STUDY DESIGN/SETTING</h3><div>This is an analytical retrospective cohort study from a single tertiary center including patients who had low-grade spondylolisthesis (Meyerding Gr I) and was treated with lumbar decompression with consequent interlaminar device (Coflex®) application performed by two fellowship-trained spine surgeons between January 1, 2017 and June 31, 2023. Ethical clearance was obtained (SL-23278).</div></div><div><h3>PATIENT SAMPLE</h3><div>Forty-seven patients who had low-grade spondylolisthesis (Meyerding Gr I) and treated with lumbar decompression with consequent interlaminar device (Coflex®) application were included.</div></div><div><h3>OUTCOME MEASURES</h3><div>Radiographic parameters – lumbar lordosis (LL), lower lumbar lordosis (LLL), intervertebral disc height (IDH), intervertebral foramen height (IFH), and vertebral translation (VT) – were obtained. Clinical outcomes were evaluated by visual analogue scale (VAS) and Oswestry disability Index (ODI).</div></div><div><h3>METHODS</h3><div>Primary outcomes were categorized as radiographic and clinical. Radiographic parameters and functional outcomes included were assessed preoperatively, postoperatively, at 1-year follow-up, and at =1-year follow-up. Descriptive statistics (mean, range, SD, frequency, percentage) were calculated. A paired Student*s t-test assessed differences in radiographic parameters and clinical outcomes. Comparisons were made across preoperative, immediate postoperative, 12-month follow-up, and latest follow-up (=1 year). Linear mixed model analysis with compound symmetry evaluated significant changes over time. Statistical significance was set at p< 0.05.</div></div><div><h3>RESULTS</h3><div>A total of 47 patients (mean age 57 years, range 30-92) with 50 implanted levels were included in the study. Following surgical decompression and interlaminar device placement, LL showed a slight but non-significant decrease [42.89° ± 10.08 to 40.33° ± 8.30 (p = 0.059)] and remained stable, while LLL remained unchanged. VT improved significantly from 3.82 mm ± 3.66 mm to 1.53 mm ± 1.84 mm (p < 0.001) and remained stable until the final follow-up (p = 0.922). IDH increased significantly from 10.23 mm ± 2.33 to 12.48 mm ± 3.11 (p < 0.001), and IFH from 20.55 mm ± 3.40 to 24.05 mm ± 3.78 (p < 0.001), both showing significant decreases at 12 months but stabilizing thereafter. Clinical outcomes, including VAS (p = 0.006) and ODI (p = 0.002), showed significant improvement compared to baseline, with continued improvement until the latest follow-up. One patient experienced infection, with no reports of adjacent segment disease or subsidence.</div></div><div><h3>CONCLUSIONS</h3><div>This study demonstrates that patients with low-grade DLS treated with posterior decompressive laminotomy and interlaminar device (Coflex®) achieve and sustain significant improvements in key radiologic parameters, including LL, LLL, and VT, and spinal motion for up to six years post-surgery with minimal risks or complications. Immediate postoperative improvements in IDH and IFH were observed, with only minor changes noted at long-term follow-up. Additionally, the findings show improvement in back pain and in functional outcomes, meeting the minimal clinically important differences for VAS and ODI scores compared to baseline.</div></div><div><h3>FDA Device/Drug Status</h3><div>Coflex® Interlaminar device (FDA PMA P110008) (Approved for this indication).</div></div>\",\"PeriodicalId\":34622,\"journal\":{\"name\":\"North American Spine Society Journal\",\"volume\":\"22 \",\"pages\":\"Article 100631\"},\"PeriodicalIF\":2.5000,\"publicationDate\":\"2025-07-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"North American Spine Society Journal\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2666548425000514\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"North American Spine Society Journal","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2666548425000514","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
P7. Clinical and radiologic outcomes of the use of interlaminar device (Coflex®) among patients with low-grade lumbar spondylolisthesis: a single center study
BACKGROUND CONTEXT
Lumbar spinal fusion relieves pain in degenerative spondylolisthesis (DLS) but carries postoperative risks, including pseudoarthrosis and adjacent segment degeneration and disease, which may eventually lead to reoperation. Dynamic stabilizers, like Coflex® interlaminar device, preserve motion while ensuring stability, providing symptom relief with fewer complications and a reduced risk profile. Though research varies, recent studies highlight their benefits in low-grade DLS.
PURPOSE
This study evaluated the radiologic and clinical effectiveness of Coflex® after decompression for low-grade DLS, with follow-ups at 1 to up to 6 years to assess outcomes and complications.
STUDY DESIGN/SETTING
This is an analytical retrospective cohort study from a single tertiary center including patients who had low-grade spondylolisthesis (Meyerding Gr I) and was treated with lumbar decompression with consequent interlaminar device (Coflex®) application performed by two fellowship-trained spine surgeons between January 1, 2017 and June 31, 2023. Ethical clearance was obtained (SL-23278).
PATIENT SAMPLE
Forty-seven patients who had low-grade spondylolisthesis (Meyerding Gr I) and treated with lumbar decompression with consequent interlaminar device (Coflex®) application were included.
OUTCOME MEASURES
Radiographic parameters – lumbar lordosis (LL), lower lumbar lordosis (LLL), intervertebral disc height (IDH), intervertebral foramen height (IFH), and vertebral translation (VT) – were obtained. Clinical outcomes were evaluated by visual analogue scale (VAS) and Oswestry disability Index (ODI).
METHODS
Primary outcomes were categorized as radiographic and clinical. Radiographic parameters and functional outcomes included were assessed preoperatively, postoperatively, at 1-year follow-up, and at =1-year follow-up. Descriptive statistics (mean, range, SD, frequency, percentage) were calculated. A paired Student*s t-test assessed differences in radiographic parameters and clinical outcomes. Comparisons were made across preoperative, immediate postoperative, 12-month follow-up, and latest follow-up (=1 year). Linear mixed model analysis with compound symmetry evaluated significant changes over time. Statistical significance was set at p< 0.05.
RESULTS
A total of 47 patients (mean age 57 years, range 30-92) with 50 implanted levels were included in the study. Following surgical decompression and interlaminar device placement, LL showed a slight but non-significant decrease [42.89° ± 10.08 to 40.33° ± 8.30 (p = 0.059)] and remained stable, while LLL remained unchanged. VT improved significantly from 3.82 mm ± 3.66 mm to 1.53 mm ± 1.84 mm (p < 0.001) and remained stable until the final follow-up (p = 0.922). IDH increased significantly from 10.23 mm ± 2.33 to 12.48 mm ± 3.11 (p < 0.001), and IFH from 20.55 mm ± 3.40 to 24.05 mm ± 3.78 (p < 0.001), both showing significant decreases at 12 months but stabilizing thereafter. Clinical outcomes, including VAS (p = 0.006) and ODI (p = 0.002), showed significant improvement compared to baseline, with continued improvement until the latest follow-up. One patient experienced infection, with no reports of adjacent segment disease or subsidence.
CONCLUSIONS
This study demonstrates that patients with low-grade DLS treated with posterior decompressive laminotomy and interlaminar device (Coflex®) achieve and sustain significant improvements in key radiologic parameters, including LL, LLL, and VT, and spinal motion for up to six years post-surgery with minimal risks or complications. Immediate postoperative improvements in IDH and IFH were observed, with only minor changes noted at long-term follow-up. Additionally, the findings show improvement in back pain and in functional outcomes, meeting the minimal clinically important differences for VAS and ODI scores compared to baseline.
FDA Device/Drug Status
Coflex® Interlaminar device (FDA PMA P110008) (Approved for this indication).